Figure 2.

Levels of IgA/G/M anticardiolipin (anti-CL) and anti–β₂ glycoprotein I (anti-β₂GPI) antibodies tested with particle-based multi-analyte technology among Sudanese women. (a), (c) and (e) IgA/G/M anti-CL and (b), (d) and (f) IgA/G/M anti-β₂GPI levels among healthy non-pregnant, pregnant and recently delivered females. Horizontal dotted lines represent the 95th and 99th percentiles among the healthy non-pregnant women. Median fluorescence intensity (MFI) is a raw measurement unit and not a final calibrated unit. Comparisons between individual groups were made for those antibodies showing an overall significant difference between the three groups. *p < 0.05, **p < 0.01, ***p < 0.001, NS: not significant.